Coforge FY26 Annual Earnings Summary
4 quarters covered · ₹16,357 Cr revenue · ₹1,744 Cr PAT · 8.9% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q1 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY26Risks flagged during the year
Tariff uncertainties and macro volatility continue to cause oscillation in run-the-enterprise budgets, potentially affecting discretionary spending.
Q1 FY26 · mediumRamp-up of the largest deal and increased visa costs, subcontractor expenses, and depreciation weighed on margins in Q1; wage hike in Q3 could pose further headwinds.
Q2 FY26 · mediumAnnual wage hike effective October 1, 2025, expected to cause a 100-150 bps margin drop in Q3, partially offset by other levers.
Q2 FY26 · mediumEMEA has seen delays and slowdowns in deal sign-offs, though management expects recovery in the next two quarters.
Q3 FY26 · mediumIntegration of Encora may face challenges in achieving synergies and margin targets, with integration expenses expected in Q4 and Q1.
Q3 FY26 · mediumHedge losses of INR 434 million in Q3 adversely impacted reported EBIT by 26bps; management is revisiting hedging strategy but no final decision yet.
Q4 FY26 · mediumBFS revenue grew only 12% in FY26, stuck at ~$120-123M for five quarters due to a large client account issue. Recovery depends on management's refactoring efforts.
Q4 FY26 · mediumIndustry-wide AI-driven code generation could compress billing rates, though management argues total cost of ownership remains high and managed services will offset.
Q1 FY26 · lowThe merger closure depends on regulatory approvals, which could slip beyond the December-January timeline.
Q1 FY26 · lowHigher CapEx for the AI data center deal impacted free cash flow; while management expects normalization, sustained asset-heavy deals could strain cash generation.
Q2 FY26 · lowManagement expects furloughs at the same scale as previous years, which could affect Q4 revenue sequentially.
Q2 FY26 · lowHedge losses doubled to INR 307 million in Q2, creating a 150 bps gap between constant currency and dollar revenue growth.
What changed through the year
Q1 FY26 · 14% EBIT margin target for FY26
Management reiterated a pathway to 14% reported EBIT margin for the full fiscal year, supported by operational leverage and cost optimization.
Q1 FY26 · At least 20 large deals in FY26
The company aims to close at least 20 large deals in the current fiscal year, up from 14 in the prior year.
Q1 FY26 · H2 growth stronger than H1
Management expects second half revenue growth to be much stronger than first half due to large deal ramp-ups.
Q1 FY26 · Signiti merger closure by Dec 2025/Jan 2026
The merger with Signiti is expected to close by December 2025 or January 2026, with effective date of April 1, 2025.
Q2 FY26 · 14% EBIT margin target for FY26
Management targets a reported EBIT margin of 14% for the full fiscal year, with Q4 expected to achieve this level despite wage hike headwinds in Q3.
Q2 FY26 · H2 FY26 growth to be robust
Management expects H2 to be a growth half over H1, with Q4 traditionally the strongest quarter, supported by pipeline and deal momentum.
Q2 FY26 · Free cash flow to PAT ratio of 70-80%
On a sustained basis, free cash flow to PAT is expected to be around 70-80%, with focus on maintaining this metric.
Q2 FY26 · Healthcare vertical to approach $100M run rate
Healthcare book of business expected to be near $100 million by end of FY26, with potential separate reporting from Q1 FY27.
Q3 FY26 · 14% EBIT margin for FY26
Management reiterated guidance of 14% EBIT margin for full fiscal year 2026, with Q4 expected to deliver 15% EBIT.
Q3 FY26 · Exceptional FY27 growth
Management expects FY27 to be an exceptional year, with continued robust growth driven by large deal pipeline and key account momentum.
Q3 FY26 · No EPS dilution from Encora in FY27
Management confirmed that the guidance of no EPS dilution in FY27 for the combined business remains intact, even after finalizing a term loan instead of QIP.
Q4 FY26 · FY27 Consolidated EBITDA Margin 20.5-21%
Management guided EBITDA margins of 20.5% to 21% for FY27 on a consolidated basis, driven by AI automation, G&A leverage, and Enkora synergies.
Q4 FY26 · FY27 Standalone EBIT Margin 16.5-17%
Standalone EBIT margin expected between 16.5% and 17% in FY27, excluding Enkora amortization.
Q4 FY26 · FCF to PAT at 100%+ from FY27
Free cash flow to PAT ratio expected to be at least 100% from FY27 onwards, up from earlier guidance of 70-80%.
Q4 FY26 · Q1 FY27 Revenue Flattish QoQ Due to India Business Exit
Revenue in Q1 FY27 expected to be flattish sequentially due to discontinuation of ~$20M low-margin India business, with growth resuming from Q2.